Consistent Kidney Benefits With Semaglutide vs. Placebo Regardless of Baseline Urine Albumin Creatinine Ratio in Subjects With Type 2 Diabetes at High Cardiovascular Risk: A Post Hoc Analysis of SUSTAIN 6: SA-PO268

Consistent Kidney Benefits With Semaglutide vs. Placebo Regardless of Baseline Urine Albumin Creatinine Ratio in Subjects With Type 2 Diabetes at High Cardiovascular Risk: A Post Hoc Analysis of SUSTAIN 6: SA-PO268

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American Society of Nephrology 2022-11, Vol.33 (11S), p.676-676
Hauptverfasser: Heerspink, Hiddo J. L, Kuhlman, Anja B., Mann, Johannes F., Rasmussen, Soren, Rossing, Peter, Vrhnjak, Blaz, Cherney, David
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 676
container_issue 11S
container_start_page 676
container_title Journal of the American Society of Nephrology
container_volume 33
creator Heerspink, Hiddo J. L
Kuhlman, Anja B.
Mann, Johannes F.
Rasmussen, Soren
Rossing, Peter
Vrhnjak, Blaz
Cherney, David
description
doi_str_mv 10.1681/ASN.20223311S1676c
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1681_ASN_20223311S1676c</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1681_ASN_20223311S1676c</sourcerecordid><originalsourceid>FETCH-crossref_primary_10_1681_ASN_20223311S1676c3</originalsourceid><addsrcrecordid>eNqdkE1Ow0AMhWcBEuXnAqx8gZZMAhPELg2gIqSqalqxjCap07pMZ6rxpFLuyKFIJFiwZWNbT_Z71ifErYwmUj3Ku6yYT-IojpNEykKqVNVnYiSjezVWKk0uxCXzPorkQ5ymI_GVO8vEAW2Ad9pY7GCKFhsKDB8UdlDgQW9NG2iDcOIJLIyusXKwxK32G4PM4BqYakZDFmHth5qZqj2QhdyjDmQHadkPDnqtaKs91r_2q-6IEMMz6QoDMugAM9ruIO_NyZ00163RHpbEn0-QwcJxv-BqyKw2Xf_4EF6si1X2Ngd1Lc4bbRhvfvqViF9fVvlsXHvH7LEpj54O2neljMqBVdmzKv-ySv519A0URHaa</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Consistent Kidney Benefits With Semaglutide vs. Placebo Regardless of Baseline Urine Albumin Creatinine Ratio in Subjects With Type 2 Diabetes at High Cardiovascular Risk: A Post Hoc Analysis of SUSTAIN 6: SA-PO268</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Heerspink, Hiddo J. L ; Kuhlman, Anja B. ; Mann, Johannes F. ; Rasmussen, Soren ; Rossing, Peter ; Vrhnjak, Blaz ; Cherney, David</creator><creatorcontrib>Heerspink, Hiddo J. L ; Kuhlman, Anja B. ; Mann, Johannes F. ; Rasmussen, Soren ; Rossing, Peter ; Vrhnjak, Blaz ; Cherney, David</creatorcontrib><identifier>ISSN: 1046-6673</identifier><identifier>DOI: 10.1681/ASN.20223311S1676c</identifier><language>eng</language><ispartof>Journal of the American Society of Nephrology, 2022-11, Vol.33 (11S), p.676-676</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27911,27912</link.rule.ids></links><search><creatorcontrib>Heerspink, Hiddo J. L</creatorcontrib><creatorcontrib>Kuhlman, Anja B.</creatorcontrib><creatorcontrib>Mann, Johannes F.</creatorcontrib><creatorcontrib>Rasmussen, Soren</creatorcontrib><creatorcontrib>Rossing, Peter</creatorcontrib><creatorcontrib>Vrhnjak, Blaz</creatorcontrib><creatorcontrib>Cherney, David</creatorcontrib><title>Consistent Kidney Benefits With Semaglutide vs. Placebo Regardless of Baseline Urine Albumin Creatinine Ratio in Subjects With Type 2 Diabetes at High Cardiovascular Risk: A Post Hoc Analysis of SUSTAIN 6: SA-PO268</title><title>Journal of the American Society of Nephrology</title><issn>1046-6673</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNqdkE1Ow0AMhWcBEuXnAqx8gZZMAhPELg2gIqSqalqxjCap07pMZ6rxpFLuyKFIJFiwZWNbT_Z71ifErYwmUj3Ku6yYT-IojpNEykKqVNVnYiSjezVWKk0uxCXzPorkQ5ymI_GVO8vEAW2Ad9pY7GCKFhsKDB8UdlDgQW9NG2iDcOIJLIyusXKwxK32G4PM4BqYakZDFmHth5qZqj2QhdyjDmQHadkPDnqtaKs91r_2q-6IEMMz6QoDMugAM9ruIO_NyZ00163RHpbEn0-QwcJxv-BqyKw2Xf_4EF6si1X2Ngd1Lc4bbRhvfvqViF9fVvlsXHvH7LEpj54O2neljMqBVdmzKv-ySv519A0URHaa</recordid><startdate>202211</startdate><enddate>202211</enddate><creator>Heerspink, Hiddo J. L</creator><creator>Kuhlman, Anja B.</creator><creator>Mann, Johannes F.</creator><creator>Rasmussen, Soren</creator><creator>Rossing, Peter</creator><creator>Vrhnjak, Blaz</creator><creator>Cherney, David</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>202211</creationdate><title>Consistent Kidney Benefits With Semaglutide vs. Placebo Regardless of Baseline Urine Albumin Creatinine Ratio in Subjects With Type 2 Diabetes at High Cardiovascular Risk: A Post Hoc Analysis of SUSTAIN 6</title><author>Heerspink, Hiddo J. L ; Kuhlman, Anja B. ; Mann, Johannes F. ; Rasmussen, Soren ; Rossing, Peter ; Vrhnjak, Blaz ; Cherney, David</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-crossref_primary_10_1681_ASN_20223311S1676c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Heerspink, Hiddo J. L</creatorcontrib><creatorcontrib>Kuhlman, Anja B.</creatorcontrib><creatorcontrib>Mann, Johannes F.</creatorcontrib><creatorcontrib>Rasmussen, Soren</creatorcontrib><creatorcontrib>Rossing, Peter</creatorcontrib><creatorcontrib>Vrhnjak, Blaz</creatorcontrib><creatorcontrib>Cherney, David</creatorcontrib><collection>CrossRef</collection><jtitle>Journal of the American Society of Nephrology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Heerspink, Hiddo J. L</au><au>Kuhlman, Anja B.</au><au>Mann, Johannes F.</au><au>Rasmussen, Soren</au><au>Rossing, Peter</au><au>Vrhnjak, Blaz</au><au>Cherney, David</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Consistent Kidney Benefits With Semaglutide vs. Placebo Regardless of Baseline Urine Albumin Creatinine Ratio in Subjects With Type 2 Diabetes at High Cardiovascular Risk: A Post Hoc Analysis of SUSTAIN 6: SA-PO268</atitle><jtitle>Journal of the American Society of Nephrology</jtitle><date>2022-11</date><risdate>2022</risdate><volume>33</volume><issue>11S</issue><spage>676</spage><epage>676</epage><pages>676-676</pages><issn>1046-6673</issn><doi>10.1681/ASN.20223311S1676c</doi></addata></record>
fulltext fulltext
identifier ISSN: 1046-6673
ispartof Journal of the American Society of Nephrology, 2022-11, Vol.33 (11S), p.676-676
issn 1046-6673
language eng
recordid cdi_crossref_primary_10_1681_ASN_20223311S1676c
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
title Consistent Kidney Benefits With Semaglutide vs. Placebo Regardless of Baseline Urine Albumin Creatinine Ratio in Subjects With Type 2 Diabetes at High Cardiovascular Risk: A Post Hoc Analysis of SUSTAIN 6: SA-PO268
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T13%3A34%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Consistent%20Kidney%20Benefits%20With%20Semaglutide%20vs.%20Placebo%20Regardless%20of%20Baseline%20Urine%20Albumin%20Creatinine%20Ratio%20in%20Subjects%20With%20Type%202%20Diabetes%20at%20High%20Cardiovascular%20Risk:%20A%20Post%20Hoc%20Analysis%20of%20SUSTAIN%206:%20SA-PO268&rft.jtitle=Journal%20of%20the%20American%20Society%20of%20Nephrology&rft.au=Heerspink,%20Hiddo%20J.%20L&rft.date=2022-11&rft.volume=33&rft.issue=11S&rft.spage=676&rft.epage=676&rft.pages=676-676&rft.issn=1046-6673&rft_id=info:doi/10.1681/ASN.20223311S1676c&rft_dat=%3Ccrossref%3E10_1681_ASN_20223311S1676c%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true